North America Microbiome Diagnostics Market Size, Share & Trends Analysis Report By Application, By Product (Reagents & Kits and Instruments), By Sample (Fecal, Saliva, Skin, and Others), By Technology, By End User, By Country and Growth Forecast, 2023 - 2030
Published Date : 01-Apr-2024 |
Pages: 123 |
Formats: PDF |
COVID-19 Impact on the North America Microbiome Diagnostics Market
Market Overview
The North America Microbiome Diagnostics Market would witness market growth of 16.9% CAGR during the forecast period (2023-2030).
The US market dominated the North America Microbiome Diagnostics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $157,641.6 Thousands by 2030. The Canada market is exhibiting a CAGR of 19.5% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 19.1% during (2023 - 2030).
It is increasingly integrated into clinical practice, particularly in gastroenterology, oncology, immunology, dermatology, and women’s health. Clinicians utilize microbiome diagnostics to aid in disease diagnosis, risk assessment, treatment selection, and monitoring of therapeutic responses. For example, in gastroenterology, it helps identify microbial biomarkers associated with inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer, guiding personalized treatment strategies and dietary interventions. In dermatology, it is used to study the skin microbiome and its role in dermatological conditions such as acne, eczema, and psoriasis, informing skincare interventions and therapeutic approaches. The adoption of microbiome diagnostics in clinical settings is driven by the need for more precise and personalized healthcare solutions tailored to individual patient characteristics and microbial profiles.
Additionally, it is widely utilized in research laboratories to investigate microbiome-host interactions, disease mechanisms, and therapeutic targets. Academic institutions, biotechnology companies, and pharmaceutical firms invest in microbiome research initiatives, leveraging microbiome diagnostics to drive innovation in drug discovery, biomarker identification, and therapeutic development. Researchers utilize microbiome diagnostics to study microbial communities’ composition, diversity, and function in various disease states, environmental contexts, and experimental models. It enables researchers to unravel the complex relationships between microbial communities and host physiology, paving the way for discoveries and breakthroughs in microbiome research.
Mexico’s pharmaceutical sector’s growth can provide financial resources and infrastructure support for clinical trials and research initiatives focused on microbiome-based interventions. The pharmaceutical sector in Mexico is divided into patented medicines, which represent 51 percent of the market by value, generics, which represent 35 percent, and over-the-counter products, which represent the remaining 14 percent. As the pharmaceutical sector expands in Mexico, there may be a growing interest in microbiome-based therapeutics for various diseases and conditions. Hence, the increasing investments in the healthcare sector and the rising pharmaceutical industry in the region are propelling the market’s growth.
Free Valuable Insights: The Microbiome Diagnostics Market is Predict to reach USD 416.1 Million by 2030, at a CAGR of 17.5%
Based on Application, the market is segmented into Disease Diagnostics (Gastrointestinal Disorders, Metabolic Diseases and Others) and Research Application. Based on Product, the market is segmented into Reagents & Kits and Instruments. Based on Sample, the market is segmented into Fecal, Saliva, Skin, and Others. Based on Technology, the market is segmented into 16S rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics and Others. Based on End User, the market is segmented into Hospitals, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Illumina, Inc.
- Becton, Dickinson and Company
- Genetic Analysis AS
- Microba Life Sciences Limited
- BioMe Oxford Ltd
- Viome Life Sciences, Inc.
- GoodGut S.L.U. (HIPRA, S.A.)
- Sun Genomics
- Origin Sciences Limited
- Decode Age
North America Microbiome Diagnostics Market Report Segmentation
By Application
- Disease Diagnostics
- Gastrointestinal Disorders
- Metabolic Diseases
- Others
- Research Application
By Product
- Reagents & Kits
- Instruments
By Sample
- Fecal
- Saliva
- Skin
- Others
By Technology
- 16S rRNA Sequencing
- Shot Gun Metagenomics
- Metatranscriptomics
- Others
By End User
- Hospitals
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Microbiome Diagnostics Market, by Application
1.4.2 North America Microbiome Diagnostics Market, by Product
1.4.3 North America Microbiome Diagnostics Market, by Sample
1.4.4 North America Microbiome Diagnostics Market, by Technology
1.4.5 North America Microbiome Diagnostics Market, by End User
1.4.6 North America Microbiome Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. North America Microbiome Diagnostics Market by Application
5.1 North America Disease Diagnostics Market by Region
5.2 North America Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 North America Gastrointestinal Disorders Market by Country
5.2.2 North America Metabolic Diseases Market by Country
5.2.3 North America Others Market by Country
5.3 North America Research Application Market by Region
Chapter 6. North America Microbiome Diagnostics Market by Product
6.1 North America Reagents & Kits Market by Country
6.2 North America Instruments Market by Country
Chapter 7. North America Microbiome Diagnostics Market by Sample
7.1 North America Fecal Market by Country
7.2 North America Saliva Market by Country
7.3 North America Skin Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Microbiome Diagnostics Market by Technology
8.1 North America 16S rRNA Sequencing Market by Country
8.2 North America Shot Gun Metagenomics Market by Country
8.3 North America Metatranscriptomics Market by Country
8.4 North America Others Market by Country
Chapter 9. North America Microbiome Diagnostics Market by End User
9.1 North America Hospitals Market by Country
9.2 North America Academic & Research Institutes Market by Country
9.3 North America Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10. North America Microbiome Diagnostics Market by Country
10.1 US Microbiome Diagnostics Market
10.1.1 US Microbiome Diagnostics Market by Application
10.1.1.1 US Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 US Microbiome Diagnostics Market by Product
10.1.3 US Microbiome Diagnostics Market by Sample
10.1.4 US Microbiome Diagnostics Market by Technology
10.1.5 US Microbiome Diagnostics Market by End User
10.2 Canada Microbiome Diagnostics Market
10.2.1 Canada Microbiome Diagnostics Market by Application
10.2.1.1 Canada Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 Canada Microbiome Diagnostics Market by Product
10.2.3 Canada Microbiome Diagnostics Market by Sample
10.2.4 Canada Microbiome Diagnostics Market by Technology
10.2.5 Canada Microbiome Diagnostics Market by End User
10.3 Mexico Microbiome Diagnostics Market
10.3.1 Mexico Microbiome Diagnostics Market by Application
10.3.1.1 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 Mexico Microbiome Diagnostics Market by Product
10.3.3 Mexico Microbiome Diagnostics Market by Sample
10.3.4 Mexico Microbiome Diagnostics Market by Technology
10.3.5 Mexico Microbiome Diagnostics Market by End User
10.4 Rest of North America Microbiome Diagnostics Market
10.4.1 Rest of North America Microbiome Diagnostics Market by Application
10.4.1.1 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Rest of North America Microbiome Diagnostics Market by Product
10.4.3 Rest of North America Microbiome Diagnostics Market by Sample
10.4.4 Rest of North America Microbiome Diagnostics Market by Technology
10.4.5 Rest of North America Microbiome Diagnostics Market by End User
Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Microbiome Diagnostics Market, by Application
1.4.2 North America Microbiome Diagnostics Market, by Product
1.4.3 North America Microbiome Diagnostics Market, by Sample
1.4.4 North America Microbiome Diagnostics Market, by Technology
1.4.5 North America Microbiome Diagnostics Market, by End User
1.4.6 North America Microbiome Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. North America Microbiome Diagnostics Market by Application
5.1 North America Disease Diagnostics Market by Region
5.2 North America Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 North America Gastrointestinal Disorders Market by Country
5.2.2 North America Metabolic Diseases Market by Country
5.2.3 North America Others Market by Country
5.3 North America Research Application Market by Region
Chapter 6. North America Microbiome Diagnostics Market by Product
6.1 North America Reagents & Kits Market by Country
6.2 North America Instruments Market by Country
Chapter 7. North America Microbiome Diagnostics Market by Sample
7.1 North America Fecal Market by Country
7.2 North America Saliva Market by Country
7.3 North America Skin Market by Country
7.4 North America Others Market by Country
Chapter 8. North America Microbiome Diagnostics Market by Technology
8.1 North America 16S rRNA Sequencing Market by Country
8.2 North America Shot Gun Metagenomics Market by Country
8.3 North America Metatranscriptomics Market by Country
8.4 North America Others Market by Country
Chapter 9. North America Microbiome Diagnostics Market by End User
9.1 North America Hospitals Market by Country
9.2 North America Academic & Research Institutes Market by Country
9.3 North America Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10. North America Microbiome Diagnostics Market by Country
10.1 US Microbiome Diagnostics Market
10.1.1 US Microbiome Diagnostics Market by Application
10.1.1.1 US Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 US Microbiome Diagnostics Market by Product
10.1.3 US Microbiome Diagnostics Market by Sample
10.1.4 US Microbiome Diagnostics Market by Technology
10.1.5 US Microbiome Diagnostics Market by End User
10.2 Canada Microbiome Diagnostics Market
10.2.1 Canada Microbiome Diagnostics Market by Application
10.2.1.1 Canada Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 Canada Microbiome Diagnostics Market by Product
10.2.3 Canada Microbiome Diagnostics Market by Sample
10.2.4 Canada Microbiome Diagnostics Market by Technology
10.2.5 Canada Microbiome Diagnostics Market by End User
10.3 Mexico Microbiome Diagnostics Market
10.3.1 Mexico Microbiome Diagnostics Market by Application
10.3.1.1 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 Mexico Microbiome Diagnostics Market by Product
10.3.3 Mexico Microbiome Diagnostics Market by Sample
10.3.4 Mexico Microbiome Diagnostics Market by Technology
10.3.5 Mexico Microbiome Diagnostics Market by End User
10.4 Rest of North America Microbiome Diagnostics Market
10.4.1 Rest of North America Microbiome Diagnostics Market by Application
10.4.1.1 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Rest of North America Microbiome Diagnostics Market by Product
10.4.3 Rest of North America Microbiome Diagnostics Market by Sample
10.4.4 Rest of North America Microbiome Diagnostics Market by Technology
10.4.5 Rest of North America Microbiome Diagnostics Market by End User
Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview
List of Tables
TABLE 1 North America Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 2 North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 3 North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 4 North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 5 North America Disease Diagnostics Market by Region, 2019 - 2022, USD Thousands
TABLE 6 North America Disease Diagnostics Market by Region, 2023 - 2030, USD Thousands
TABLE 7 North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 8 North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 9 North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
TABLE 10 North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
TABLE 11 North America Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
TABLE 12 North America Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
TABLE 13 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 14 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 15 North America Research Application Market by Region, 2019 - 2022, USD Thousands
TABLE 16 North America Research Application Market by Region, 2023 - 2030, USD Thousands
TABLE 17 North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 18 North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 19 North America Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
TABLE 20 North America Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
TABLE 21 North America Instruments Market by Country, 2019 - 2022, USD Thousands
TABLE 22 North America Instruments Market by Country, 2023 - 2030, USD Thousands
TABLE 23 North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 24 North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 25 North America Fecal Market by Country, 2019 - 2022, USD Thousands
TABLE 26 North America Fecal Market by Country, 2023 - 2030, USD Thousands
TABLE 27 North America Saliva Market by Country, 2019 - 2022, USD Thousands
TABLE 28 North America Saliva Market by Country, 2023 - 2030, USD Thousands
TABLE 29 North America Skin Market by Country, 2019 - 2022, USD Thousands
TABLE 30 North America Skin Market by Country, 2023 - 2030, USD Thousands
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 33 North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 34 North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 35 North America 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
TABLE 36 North America 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
TABLE 37 North America Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
TABLE 38 North America Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
TABLE 39 North America Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
TABLE 40 North America Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
TABLE 41 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 42 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 43 North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 44 North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 45 North America Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 46 North America Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 47 North America Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
TABLE 48 North America Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
TABLE 49 North America Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
TABLE 50 North America Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
TABLE 51 North America Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 52 North America Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 53 US Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 54 US Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 55 US Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 56 US Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 57 US Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 58 US Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 59 US Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 60 US Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 61 US Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 62 US Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 63 US Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 64 US Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 65 US Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 66 US Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 67 Canada Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 68 Canada Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 69 Canada Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 70 Canada Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 71 Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 72 Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 73 Canada Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 74 Canada Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 75 Canada Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 76 Canada Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 77 Canada Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 78 Canada Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 79 Canada Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 80 Canada Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 81 Mexico Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 82 Mexico Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 83 Mexico Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 84 Mexico Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 85 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 86 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 87 Mexico Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 88 Mexico Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 89 Mexico Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 90 Mexico Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 91 Mexico Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 92 Mexico Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 93 Mexico Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 94 Mexico Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 95 Rest of North America Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 96 Rest of North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 97 Rest of North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 98 Rest of North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 99 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 100 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 101 Rest of North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 102 Rest of North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 103 Rest of North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 104 Rest of North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 105 Rest of North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 106 Rest of North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 107 Rest of North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 108 Rest of North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 109 key information – Illumina, Inc.
TABLE 110 Key Information – Becton, Dickinson and Company
TABLE 111 Key Information – Genetic Analysis AS
TABLE 112 Key Information – Microba Life Sciences Limited
TABLE 113 Key Information –BioMe Oxford Ltd
TABLE 114 Key Information – Viome Life Sciences, Inc.
TABLE 115 Key Information – GoodGut S.L.U.
TABLE 116 Key Information – Sun Genomics
TABLE 117 Key Information – Origin Sciences Limited
TABLE 118 Key Information – Decode Age
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Microbiome Diagnostics Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Microbiome Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Microbiome Diagnostics Market
FIG 5 North America Microbiome Diagnostics Market share by Application, 2022
FIG 6 North America Microbiome Diagnostics Market share by Application, 2030
FIG 7 North America Microbiome Diagnostics Market by Application, 2019 - 2030, USD Thousands
FIG 8 North America Microbiome Diagnostics Market share by Product, 2022
FIG 9 North America Microbiome Diagnostics Market share by Product, 2030
FIG 10 North America Microbiome Diagnostics Market by Product, 2019 - 2030, USD Thousands
FIG 11 North America Microbiome Diagnostics Market share by Sample, 2022
FIG 12 North America Microbiome Diagnostics Market share by Sample, 2030
FIG 13 North America Microbiome Diagnostics Market by Sample, 2019 - 2030, USD Thousands
FIG 14 North America Microbiome Diagnostics Market share by Technology, 2022
FIG 15 North America Microbiome Diagnostics Market share by Technology, 2030
FIG 16 North America Microbiome Diagnostics Market by Technology, 2019 - 2030, USD Thousands
FIG 17 North America Microbiome Diagnostics Market share by End User, 2022
FIG 18 North America Microbiome Diagnostics Market share by End User, 2030
FIG 19 North America Microbiome Diagnostics Market by End User, 2019 - 2030, USD Thousands
FIG 20 North America Microbiome Diagnostics Market share by Country, 2022
FIG 21 North America Microbiome Diagnostics Market share by Country, 2030
FIG 22 North America Microbiome Diagnostics Market by Country, 2019 - 2030, USD Thousands
FIG 23 Swot Analysis: Illumina, Inc.
FIG 24 Recent strategies and developments: Becton, Dickinson, and Company
FIG 25 SWOT Analysis: Becton, Dickinson and company
FIG 26 Recent strategies and developments: Microba Life Sciences
FIG 27 Recent strategies and developments: Viome Life Sciences
TABLE 2 North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 3 North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 4 North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 5 North America Disease Diagnostics Market by Region, 2019 - 2022, USD Thousands
TABLE 6 North America Disease Diagnostics Market by Region, 2023 - 2030, USD Thousands
TABLE 7 North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 8 North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 9 North America Gastrointestinal Disorders Market by Country, 2019 - 2022, USD Thousands
TABLE 10 North America Gastrointestinal Disorders Market by Country, 2023 - 2030, USD Thousands
TABLE 11 North America Metabolic Diseases Market by Country, 2019 - 2022, USD Thousands
TABLE 12 North America Metabolic Diseases Market by Country, 2023 - 2030, USD Thousands
TABLE 13 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 14 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 15 North America Research Application Market by Region, 2019 - 2022, USD Thousands
TABLE 16 North America Research Application Market by Region, 2023 - 2030, USD Thousands
TABLE 17 North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 18 North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 19 North America Reagents & Kits Market by Country, 2019 - 2022, USD Thousands
TABLE 20 North America Reagents & Kits Market by Country, 2023 - 2030, USD Thousands
TABLE 21 North America Instruments Market by Country, 2019 - 2022, USD Thousands
TABLE 22 North America Instruments Market by Country, 2023 - 2030, USD Thousands
TABLE 23 North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 24 North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 25 North America Fecal Market by Country, 2019 - 2022, USD Thousands
TABLE 26 North America Fecal Market by Country, 2023 - 2030, USD Thousands
TABLE 27 North America Saliva Market by Country, 2019 - 2022, USD Thousands
TABLE 28 North America Saliva Market by Country, 2023 - 2030, USD Thousands
TABLE 29 North America Skin Market by Country, 2019 - 2022, USD Thousands
TABLE 30 North America Skin Market by Country, 2023 - 2030, USD Thousands
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 33 North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 34 North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 35 North America 16S rRNA Sequencing Market by Country, 2019 - 2022, USD Thousands
TABLE 36 North America 16S rRNA Sequencing Market by Country, 2023 - 2030, USD Thousands
TABLE 37 North America Shot Gun Metagenomics Market by Country, 2019 - 2022, USD Thousands
TABLE 38 North America Shot Gun Metagenomics Market by Country, 2023 - 2030, USD Thousands
TABLE 39 North America Metatranscriptomics Market by Country, 2019 - 2022, USD Thousands
TABLE 40 North America Metatranscriptomics Market by Country, 2023 - 2030, USD Thousands
TABLE 41 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 42 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 43 North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 44 North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 45 North America Hospitals Market by Country, 2019 - 2022, USD Thousands
TABLE 46 North America Hospitals Market by Country, 2023 - 2030, USD Thousands
TABLE 47 North America Academic & Research Institutes Market by Country, 2019 - 2022, USD Thousands
TABLE 48 North America Academic & Research Institutes Market by Country, 2023 - 2030, USD Thousands
TABLE 49 North America Biotechnology & Pharmaceutical Companies Market by Country, 2019 - 2022, USD Thousands
TABLE 50 North America Biotechnology & Pharmaceutical Companies Market by Country, 2023 - 2030, USD Thousands
TABLE 51 North America Microbiome Diagnostics Market by Country, 2019 - 2022, USD Thousands
TABLE 52 North America Microbiome Diagnostics Market by Country, 2023 - 2030, USD Thousands
TABLE 53 US Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 54 US Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 55 US Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 56 US Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 57 US Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 58 US Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 59 US Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 60 US Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 61 US Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 62 US Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 63 US Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 64 US Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 65 US Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 66 US Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 67 Canada Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 68 Canada Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 69 Canada Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 70 Canada Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 71 Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 72 Canada Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 73 Canada Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 74 Canada Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 75 Canada Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 76 Canada Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 77 Canada Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 78 Canada Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 79 Canada Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 80 Canada Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 81 Mexico Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 82 Mexico Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 83 Mexico Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 84 Mexico Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 85 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 86 Mexico Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 87 Mexico Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 88 Mexico Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 89 Mexico Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 90 Mexico Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 91 Mexico Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 92 Mexico Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 93 Mexico Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 94 Mexico Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 95 Rest of North America Microbiome Diagnostics Market, 2019 - 2022, USD Thousands
TABLE 96 Rest of North America Microbiome Diagnostics Market, 2023 - 2030, USD Thousands
TABLE 97 Rest of North America Microbiome Diagnostics Market by Application, 2019 - 2022, USD Thousands
TABLE 98 Rest of North America Microbiome Diagnostics Market by Application, 2023 - 2030, USD Thousands
TABLE 99 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2019 - 2022, USD Thousands
TABLE 100 Rest of North America Microbiome Diagnostics Market by Disease Diagnostics Type, 2023 - 2030, USD Thousands
TABLE 101 Rest of North America Microbiome Diagnostics Market by Product, 2019 - 2022, USD Thousands
TABLE 102 Rest of North America Microbiome Diagnostics Market by Product, 2023 - 2030, USD Thousands
TABLE 103 Rest of North America Microbiome Diagnostics Market by Sample, 2019 - 2022, USD Thousands
TABLE 104 Rest of North America Microbiome Diagnostics Market by Sample, 2023 - 2030, USD Thousands
TABLE 105 Rest of North America Microbiome Diagnostics Market by Technology, 2019 - 2022, USD Thousands
TABLE 106 Rest of North America Microbiome Diagnostics Market by Technology, 2023 - 2030, USD Thousands
TABLE 107 Rest of North America Microbiome Diagnostics Market by End User, 2019 - 2022, USD Thousands
TABLE 108 Rest of North America Microbiome Diagnostics Market by End User, 2023 - 2030, USD Thousands
TABLE 109 key information – Illumina, Inc.
TABLE 110 Key Information – Becton, Dickinson and Company
TABLE 111 Key Information – Genetic Analysis AS
TABLE 112 Key Information – Microba Life Sciences Limited
TABLE 113 Key Information –BioMe Oxford Ltd
TABLE 114 Key Information – Viome Life Sciences, Inc.
TABLE 115 Key Information – GoodGut S.L.U.
TABLE 116 Key Information – Sun Genomics
TABLE 117 Key Information – Origin Sciences Limited
TABLE 118 Key Information – Decode Age
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Microbiome Diagnostics Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting Microbiome Diagnostics Market
FIG 4 Porter’s Five Forces Analysis – Microbiome Diagnostics Market
FIG 5 North America Microbiome Diagnostics Market share by Application, 2022
FIG 6 North America Microbiome Diagnostics Market share by Application, 2030
FIG 7 North America Microbiome Diagnostics Market by Application, 2019 - 2030, USD Thousands
FIG 8 North America Microbiome Diagnostics Market share by Product, 2022
FIG 9 North America Microbiome Diagnostics Market share by Product, 2030
FIG 10 North America Microbiome Diagnostics Market by Product, 2019 - 2030, USD Thousands
FIG 11 North America Microbiome Diagnostics Market share by Sample, 2022
FIG 12 North America Microbiome Diagnostics Market share by Sample, 2030
FIG 13 North America Microbiome Diagnostics Market by Sample, 2019 - 2030, USD Thousands
FIG 14 North America Microbiome Diagnostics Market share by Technology, 2022
FIG 15 North America Microbiome Diagnostics Market share by Technology, 2030
FIG 16 North America Microbiome Diagnostics Market by Technology, 2019 - 2030, USD Thousands
FIG 17 North America Microbiome Diagnostics Market share by End User, 2022
FIG 18 North America Microbiome Diagnostics Market share by End User, 2030
FIG 19 North America Microbiome Diagnostics Market by End User, 2019 - 2030, USD Thousands
FIG 20 North America Microbiome Diagnostics Market share by Country, 2022
FIG 21 North America Microbiome Diagnostics Market share by Country, 2030
FIG 22 North America Microbiome Diagnostics Market by Country, 2019 - 2030, USD Thousands
FIG 23 Swot Analysis: Illumina, Inc.
FIG 24 Recent strategies and developments: Becton, Dickinson, and Company
FIG 25 SWOT Analysis: Becton, Dickinson and company
FIG 26 Recent strategies and developments: Microba Life Sciences
FIG 27 Recent strategies and developments: Viome Life Sciences